SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-103493
Filing Date
2021-08-11
Accepted
2021-08-11 16:27:09
Documents
13
Period of Report
2021-08-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124824d1_8k.htm   iXBRL 8-K 31748
2 EXHIBIT 10.1 tm2124824d1_ex10-1.htm EX-10.1 107078
  Complete submission text file 0001104659-21-103493.txt   339806

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrna-20210809.xsd EX-101.SCH 3200
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrna-20210809_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrna-20210809_pre.xml EX-101.PRE 22720
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2124824d1_8k_htm.xml XML 3702
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38067 | Film No.: 211163803
SIC: 2834 Pharmaceutical Preparations